Electronic medical record cancer incidence over six years comparing new users of glargine with new users of NPH insulin. [PDF]
PLoS ONE, 2014 Recent studies suggested that insulin glargine use could be associated with increased risk of cancer. We compared the incidence of cancer in new users of glargine versus new users of NPH in a longitudinal clinical cohort with diabetes for up to 6 years ...
Soo Lim +8 more
doaj +14 more sources
Effective use of saline-diluted subcutaneous glargine in very low birth weight babies with neonatal hyperglycemia [PDF]
Journal of Family Medicine and Primary CareThis case series documents two very low birth weight neonates who presented with spontaneous hyperglycemia even after discontinuation of steroids in a critical care setting.
Akhila Bhandarkar +3 more
doaj +2 more sources
Impact of switching from neutral protamine hagedorn insulin (NPH) to glargine insulin on glycemic control and clinical outcomes in pediatric patients with type 1 diabetes [PDF]
Exploratory Research in Clinical and Social PharmacyBackground: Treatment of type 1 diabetes requires insulin therapy, and various types of insulin can be used. Insulin glargine has been shown to provide effective glycemic control with reduced hypoglycemia.
Hiba Abdelmunim Suliman Elsheikh +7 more
doaj +2 more sources
Cloning and Extracellular Expression of Glargine in Pichia pastoris
Hayati Journal of Biosciences, 2023 Patients with diabetes mellitus increase significantly every year. The increasing number of people with diabetes mellitus results in increased insulin requirements.
Dudi Hardianto +6 more
doaj +1 more source
Медицинский совет, 2021 In time, prescription of insulin therapy (IT) becomes inevitable for many patients with type 2 diabetes mellitus (DM) to achieve and maintain the target hypoglycemic range.According to the current guidelines, the addition of basal insulin to glucose ...
E. V. Biryukova +2 more
doaj +1 more source
Insulin glargine and cancer risk in patients with diabetes: a meta-analysis. [PDF]
PLoS ONE, 2012 AimThe role of insulin glargine as a risk factor for cancer is controversial in human studies. The aim of this meta-analysis was to evaluate the relationship between insulin glargine and cancer incidence.MethodsAll observational studies and randomized ...
Xulei Tang +3 more
doaj +1 more source
Effects of glargine on hyperglycemia in patients with diabetes mellitus type II undergoing off-pump coronary artery bypass graft: A randomized, controlled, double-blind clinical trial [PDF]
Journal of Cardiovascular and Thoracic Research, 2023 Introduction: In this trial, effects of glargine on hyperglycemia in patients with diabetes mellitus type II who were undergoing off-pump coronary artery bypass graft (CAGB), were examined.
Shima Sheybani +5 more
doaj +1 more source
A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks. DUAL VIII, a randomized trial designed to resemble clinical practice [PDF]
, 2020 This report presents the efficacy and safety of insulin degludec/liraglutide (IDegLira) versus insulin glargine 100 units/mL (IGlar U100) as initial injectable therapy at 26 weeks in the 104-week DUAL VIII durability trial (NCT02501161). Participants (N =
Aroda, V. R. +7 more
core +1 more source
Comparison between basal insulin glargine and NPH insulin in patients with diabetes type 1 on conventional intensive insulin therapy [PDF]
Vojnosanitetski Pregled, 2007 Background/Aim. Insulin glargine is a long-acting insulin analog that mimics normal basal insulin secretion without pronounced peaks. The aim of this study was to compare insulin glargine with isophane insulin (NPH insulin) for basal insulin supply in ...
Pešić Milica +5 more
doaj +1 more source
Insulin choice in feline diabetes mellitus
Veterinary Evidence, 2021 PICO question In cats with diabetes mellitus, do protamine zinc insulin (PZI) and glargine show a similar effect in reducing clinical signs and hypoglycaemia episodes?
Yaiza Gomez Mejias
doaj +1 more source